Phathom Pharmaceuticals, Inc.
PHAT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001783183
No open-market purchases or sales by Phathom Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $782.1M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Phathom Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 84 | 103 | +19 |
| Shares | 30.8M | 42.8M | +12.0M (+39.0%) |
| Value | $219.7M | $612.6M | +$392.9M (+178.8%) |
New holders (28)
Institutions that held Phathom Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (9)
Institutions that held Phathom Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Opaleye Management Inc. | 496,000 | $3.54M |
| Candriam Luxembourg S.C.A. | 63,778 | $419.1K |
| Marshall Wace, LLP | 37,096 | $264.9K |
| Belvedere Trading LLC | 13,525 | $96.6K |
| Point72 Asset Management, L.P. | 11,505 | $82.1K |
| SG Americas Securities, LLC | 11,328 | $81.0K |
| State Board of Administration of Florida Retirement System | 11,228 | $80.2K |
| Cubist Systematic Strategies, LLC | 1,649 | $11.8K |
| Crewe Advisors LLC | 107 | $764 |